Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Resistant to isoniazid and rifampicin

Mycobacterium tuberculosis bacteria © CDC

GRAM estimates the global prevalence of Mycobacterium tuberculosis complex infections with observed single- and multi-drug resistance to isoniazid and rifampicin. Based on a statistical analysis using data obtained from the WHO, findings are due for release in 2022.